Qiang Lu

Company: GenFleet Therapeutics

Job title: Co-Founder & Chairman

Seminars:

Fulzerasib – A Journal from Second Line to First Line 9:30 am

• From Discovery to IND: Critical criteria to accelerate the pre-clinical development process • Picking the best partner, at/for the right timing • Key to survival: Differentiated global clinical development strategy and CMCRead more

day: Day Two

Panel Discussion: Does Pan-RAS Hold the Future of Precision Medicine? Exploring Combination Potential & Targeting Novel Isoforms 9:30 am

• What is the scope for pan-RAS beyond canonical RAS isoforms? • What is the scope for targeting patient populations with NRAS isoforms? Can go as far as drugging melanoma? • What combination therapies should be deployed with pan-RAS and how can we inform this? Read more

day: Day One